PANDEMIC Defusing mini-chromosomes—the Achilles’ heel of the wheat blast pandemic
- Coordinator
- Martin-Luther-Universitat Halle-Wittenberg, Germany
- Runs
- 1 October 2023 to 30 September 2028
- Status
- Running
- EU funding
- €1.5m
- Total cost
- €1.5m
- Partners
- 2 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101077853
What the project is doing
In the project's own words, from its summary on CORDIS.
PANDEMIC is an ambitious high-risk/high-gain program to deliver an innovative pathogen-guided strategy for crop disease resistance. The wheat blast pandemic is a clear and present danger to global food security. It is caused by the blast fungus, Magnaporthe oryzae, which, after emerging in Brazil only ~35 years ago, has spread over the last 5 years to Southeast Asia and Africa. We discovered that all isolates of the pandemic wheat blast fungus belong to a single, asexual clonal lineage.
These pandemic isolates carry a supernumerary mini-chromosome (mChr) of ~2 Mb, which encodes 19 secreted effector (virulence) proteins and renders the pandemic lineage highly virulent. We propose that this mChr is the Achilles’ heel of the pandemic fungus. In PANDEMIC, my team and I will target the mChr virulence properties by gene editing and engineering of disease resistance genes that target mChr-encoded effectors.
The central hypothesis of this project is, that detailed knowledge about the biophysical properties of pathogen effector-host target interactions can guide bioengineering of non-transgenic disease resistance in wheat. To achieve our goal, we will employ a multi-disciplinary approach combining genetics, structural biology, and gene editing. Specifically, we will pursue the following objectives:1.GENETICS. Determine the mChr-encoded effectors conferring high virulence on the pandemic wheat blast fungus. 2.BIOPHYSICS.
Define the biophysical properties of effector-host target interactions.3.IMMUNITY. Apply CRISPR/Cas gene editing to deliver innovative, non-transgenic solutions for blast disease management. At the completion of this project, my team and I will generate a detailed understanding of the biophysical properties of mChr-encoded effector-target protein complexes and deliver novel traits and non-transgenic solutions for developing resistance against the pandemic wheat blast fungus.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Martin-Luther-Universitat Halle-Wittenberg | Halle | Germany | Coordinator |
| Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eV | Munchen | Germany | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI